IA
IBB icon

IFP Advisors’s iShares Biotechnology ETF IBB Stock Holding History

IFP Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.51M Buy
49,988
+14,115
+39% +$2.43M 0.17% 129
2026
Q1 		$6.06M Buy
35,873
+15,387
+75% +$2.63M 0.13% 186
2025
Q4 		$3.46M Buy
20,486
+1,424
+7% +$231K 0.08% 278
2025
Q3 		$2.75M Sell
19,062
-783
-4% -$107K 0.07% 302
2025
Q2 		$2.51M Sell
19,845
-4
-0% -$491 0.07% 305
2025
Q1 		$2.54M Buy
19,849
+3,831
+24% +$519K 0.08% 300
2024
Q4 		$2.12M Buy
16,018
+11,266
+237% +$1.58M 0.07% 325
2024
Q3 		$692K Sell
4,752
-93
-2% -$13.5K 0.02% 575
2024
Q2 		$665K Sell
4,845
-293
-6% -$39.1K 0.03% 564
2024
Q1 		$705K Sell
5,138
-447
-8% -$61K 0.03% 505
2023
Q4 		$759K Sell
5,585
-597
-10% -$72.8K 0.04% 461
2023
Q3 		$756K Sell
6,182
-562
-8% -$71.5K 0.03% 472
2023
Q2 		$856K Sell
6,744
-1,825
-21% -$237K 0.04% 475
2023
Q1 		$941K Sell
8,569
-2,827
-25% -$370K 0.04% 411
2022
Q4 		$1.25M Sell
11,396
-665
-6% -$85.9K 0.03% 536
2022
Q3 		$1.33M Buy
12,061
+292
+2% +$36.3K 0.03% 543
2022
Q2 		$1.3M Hold
11,769
– – 0.04% 492
2022
Q1 		$1.3M Buy
11,769
+1,298
+12% +$169K 0.04% 492
2021
Q4 		$1.6M Buy
10,471
+1,525
+17% +$236K 0.03% 307
2021
Q3 		$1.44M Sell
8,946
-584
-6% -$98.3K 0.03% 322
2021
Q2 		$1.55M Sell
9,530
-811
-8% -$125K 0.03% 293
2021
Q1 		$1.55M Sell
10,341
-1,081
-9% -$172K 0.03% 279
2020
Q4 		$1.72M Buy
11,422
+4,225
+59% +$604K 0.07% 234
2020
Q3 		$971K Buy
7,197
+1,760
+32% +$239K 0.06% 297
2020
Q2 		$731K Buy
5,437
+1,952
+56% +$249K 0.06% 337
2020
Q1 		$367K Sell
3,485
-3,822
-52% -$440K 0.04% 415
2019
Q4 		$887K Sell
7,307
-139
-2% -$15.5K 0.07% 310
2019
Q3 		$735K Buy
+7,446
New +$779K 0.05% 382
2019
Q1 		$2.53M Sell
22,688
-32,002
-59% -$3.51M 0.35% 65
2018
Q4 		$5.19M Sell
54,690
-48,319
-47% -$5.13M 0.32% 69
2018
Q3 		$12.6M Buy
103,009
+5,801
+6% +$683K 0.51% 29
2018
Q2 		$10.7M Sell
97,208
-27,953
-22% -$2.99M 0.45% 34
2018
Q1 		$13.4M Buy
125,161
+600
+0.5% +$66.5K 0.61% 21
2017
Q4 		$13.4M Buy
124,561
+47,488
+62% +$5.08M 0.61% 22
2017
Q3 		$8.57M Buy
77,073
+5,139
+7% +$549K 0.34% 55
2017
Q2 		$7.43M Sell
71,934
-2,445
-3% -$241K 0.32% 61
2017
Q1 		$7.27M Buy
74,379
+9,681
+15% +$927K 0.32% 67
2016
Q4 		$5.72M Buy
64,698
+31,374
+94% +$2.86M 0.28% 72
2016
Q3 		$3.21M Sell
33,324
-4,422
-12% -$421K 0.17% 128
2016
Q2 		$3.24M Sell
37,746
-30,318
-45% -$2.72M 0.18% 113
2016
Q1 		$2.53M Buy
68,064
+9,351
+16% +$836K 0.35% 65
2015
Q4 		$6.62M Buy
+58,713
New +$6.37M 0.44% 47

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

IFP Advisors's IBB Position: Q2 2026 in Review

IFP Advisors increased its iShares Biotechnology ETF (IBB) stake by 39% in Q2 2026, buying an estimated $2.43M and bringing the position to 49,988 shares worth $9.51M. The position accounts for 0.17% of the portfolio, ranked #129.

IFP Advisors first reported a position in IBB in Q4 2015 and has held it in 42 quarters since. The position peaked at $13.4M in Q1 2018. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • IFP Advisors held 49,988 shares of iShares Biotechnology ETF worth $9.51M as of Q2 2026.
  • IFP Advisors bought 14,115 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.43M.
  • iShares Biotechnology ETF made up 0.17% of IFP Advisors's portfolio in Q2 2026, its #129 holding.
  • IFP Advisors first reported a position in iShares Biotechnology ETF in Q4 2015 and has held it in 42 quarters since.
  • IFP Advisors's iShares Biotechnology ETF position peaked at $13.4M in Q1 2018.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.